⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 12 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 12 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine AT February 7, 2022

Farmorubicin 50 mg Stechampulle (Konzentrat zur Herstellung einer Infusionslösung)

📷 Wikipedia: Epirubicin · Source
Farmorubicin 50 mg Stechampulle (Konzentrat zur Herstellung einer Infusionslösung)
📷 Wikipedia: Epirubicin · Source
Farmorubicin 50 mg vial (concentrate for preparing an infusion solution) Parallel export ban in effect. Quality issues with the finished product. Marketing authorization holder: Pfizer Corporation Austria Ges.m.b.H., Floridsdorfer Hauptstraße 1, 1210 Vienna, Austria. Affected packs: 1 vial [unavailable since 4 February 2022].
🗄
Archived (older alert)
This alert was reported 1573 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
12 days in total
May 18, 2026 May 30, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Farmorubicin is a cancer medicine. It comes as a small bottle you mix with liquid for a drip.

What's happening? The maker stopped making this version because of a quality issue. The bottles are not available.

Does this affect me? If your doctor prescribed this exact bottle, you may need a different medicine or brand.

What should I do? Ask your pharmacist or doctor for another safe option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: L01DB03 · Reason: Qualitätsprobleme des Fertigproduktes · Marketing authorisation holder: Pfizer Corporation Austria Ges.m.b.H., Floridsdorfer Hauptstraße 1, 1210 Wien, Österreich · Affected packs: 1 Stück Durchstechflasche [Nicht verfügbar, since 2022-02-04]

First published
February 7, 2022
Last refreshed by us
1 week ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Farmorubicin 50 mg Stechampulle (Konzentrat zur Herstellung einer Infusionslösung). Farmorubicin 50 mg vial (concentrate for preparing an infusion solution) Parallel export ban in effect. Quality issues with the finished product. Marketing authorization holder: Pfizer Corporation Austria Ges.m.b.H., Floridsdorfer Hauptstraße 1, 1210 Vienna, Austria. Affected pa...
When was this alert issued?
This alert was issued on February 7, 2022 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.